None of the 29 investors followed here reported a position in EVH in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a EVH trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 25, 2026 | Mccarthy Daniel JosephPresident | Sale at price 5.00 per share. | 65.9K | $329.46K |
| Jun 30, 2026 | Blackley SethChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 446.1K | — |
| Jun 30, 2026 | Weinberg Jonathan D.General Counsel | Stock Award(Grant) at price 0.00 per share. | 43.1K | — |
| Jun 30, 2026 | Shams AammaadOfficer | Stock Award(Grant) at price 0.00 per share. | 28.8K | — |
| Jun 30, 2026 | Mccarthy Daniel JosephPresident | Stock Award(Grant) at price 0.00 per share. | 302.6K | — |
| Jun 3, 2026 | Grua Peter JDirector | Stock Award(Grant) at price 0.00 per share. | 41.1K | — |
| Jun 3, 2026 | Guertin Shawn MDirector | Stock Award(Grant) at price 0.00 per share. | 41.1K | — |
| Jun 3, 2026 | Jelinek Richard MDirector | Stock Award(Grant) at price 0.00 per share. | 41.1K | — |
| Jun 3, 2026 | Barbarosh Craig ADirector | Stock Award(Grant) at price 0.00 per share. | 41.1K | — |
| Jun 3, 2026 | Springstubb Brendan B.Director | Stock Award(Grant) at price 0.00 per share. | 41.1K | — |
| Jun 3, 2026 | Keck KimDirector | Stock Award(Grant) at price 0.00 per share. | 41.1K | — |
| Jun 3, 2026 | Smith Jill DDirector | Stock Award(Grant) at price 0.00 per share. | 41.1K | — |
| Jun 3, 2026 | Ajayi ToyinDirector | Stock Award(Grant) at price 0.00 per share. | 41.1K | — |
| Jun 3, 2026 | Glass Russell MonroeDirector | Stock Award(Grant) at price 0.00 per share. | 41.1K | — |
| Mar 1, 2026 | Blackley SethChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 58.9K | — |
| Mar 1, 2026 | Weinberg Jonathan D.General Counsel | Stock Award(Grant) at price 0.00 per share. | 4.9K | — |
| Mar 1, 2026 | Shams AammaadOfficer | Stock Award(Grant) at price 0.00 per share. | 1.7K | — |
| Mar 1, 2026 | Mccarthy Daniel JosephPresident | Stock Award(Grant) at price 0.00 per share. | 39.3K | — |
| Jan 1, 2026 | Smith Jill DDirector | Stock Award(Grant) at price 0.00 per share. | 23.1K | — |
| Jan 1, 2026 | Ramos MarioChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 587.5K | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -19.7 | 1.2 | -29.8 | 64.5 | 5.3 | 37.2 | -43.0 | 45.6 | -22.4 | 33.5 | +16.5% | ||
| 2025 | -7.1 | -14.0 | 5.3 | 4.1 | -24.4 | 51.1 | -10.7 | -4.0 | -12.3 | -21.2 | -37.0 | -4.8 | −64.4% |
| 2024 | -11.0 | 15.3 | -3.3 | -15.4 | -23.6 | -9.8 | 22.0 | 37.1 | -11.6 | -17.4 | -44.7 | -12.9 | −65.9% |
| 2023 | 14.7 | 8.7 | -7.3 | 12.2 | -20.0 | 4.0 | 0.3 | -16.1 | 6.7 | -10.3 | 13.8 | 18.8 | +17.6% |
| 2022 | -14.3 | 12.4 | 21.2 | -14.8 | 2.2 | 9.2 | 10.7 | 8.1 | -2.2 | -11.5 | -9.5 | -2.5 | +1.5% |
| 2021 | 6.5 | 18.0 | 0.2 | 7.2 | -10.3 | 8.7 | 8.6 | 7.1 | 26.2 | -5.6 | -11.2 | 6.4 | +72.6% |
| 2020 | 11.4 | -8.3 | -41.2 | 32.8 | 23.2 | -19.8 | 63.6 | 23.0 | -13.4 | -19.9 | 46.2 | 10.3 | +77.1% |
| 2019 | -11.4 | -25.4 | -4.6 | 7.7 | -21.5 | -25.3 | -14.2 | 0.7 | 4.7 | 6.0 | -5.4 | 25.5 | −54.6% |
| 2018 | 14.6 | 3.9 | -2.7 | 15.8 | 23.9 | 2.9 | -4.0 | 26.2 | 11.4 | -21.8 | 15.8 | -22.4 | +62.2% |
| 2017 | 23.0 | 8.2 | 13.2 | 4.3 | -1.3 | 10.5 | -2.6 | -32.4 | 6.6 | -8.7 | -20.9 | -4.3 | −16.9% |
| 2016 | -18.5 | 1.8 | 5.1 | 13.7 | 27.6 | 25.3 | 22.6 | 5.6 | -1.0 | -14.5 | -10.7 | -21.3 | +22.2% |
| 2015 | 9.4 | -20.3 | -6.1 | -19.5 | 26.7 | -25.6 | −37.9% |
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Buy / hold / sell counts